Rhode Island H8329 establishes the terminally ill patients’ right to try act.

Rhode Island H8329 establishes the terminally ill patients’ right to try act. The act allows terminally ill patients to access investigational drugs, biologics, and devices not yet approved by the FDA. It provides immunity from lawsuits for healthcare providers and facilities involved in such treatments, provided they act in good faith and without misconduct. The act also allows for telehealth prescreening and remote signing of consent forms. It aims to remove barriers to potentially life-saving treatments and attract clinical trials to Rhode Island. The act takes effect on January 1, 2027.

Rhode Island H8329 establishes the terminally ill patients’ right to try act.

Rhode Island H8329 establishes the terminally ill patients’ right to try act. The act allows terminally ill patients to access investigational drugs, biologics, and devices not yet approved by the FDA. It provides immunity from lawsuits for healthcare providers and facilities involved in such treatments, provided they act in good faith and without misconduct. The act also allows for telehealth prescreening and remote signing of consent forms. It aims to remove barriers to potentially life-saving treatments and attract clinical trials to Rhode Island. The act takes effect on January 1, 2027.